ExploreDaily DealsShop with an ExpertBuy AgainOrdersHelp & Support
Join NowHealthcare provider? Join Now
logoImage
Log In
  • Medical Supplies
  • Pharmacy
  • IV Therapy
About Us
What Makes Us Different?
Who We Are
Our Core Values
Our Testimonials
Our Culture
How Reliable Are We?
Who We Serve
Providing Cutting Edge Solution Globally
Partner With USA MedPremium
Healthcare Professional Statement
Newsroom
Quality Assurance
Our Service & Solutions
Shop with an Expert
Analytics & Reporting
Inventory Management
Distribution Solutions
Streamline Integration
Cost Effective Healthcare solutions
Supply Chain Optimization
Credit Allocation
Customer Service
Live Chat Support
Contact Us
Shipping & Returns
Terms & Conditions
Order Status
Account
Log In
Forgot Password
Healthcare Provider? Join Now
USA MedPremium
LegitScript Certified
LegitScript CertifiedVerified Healthcare Distributor
Follow us:
©2026 USA MedPremium. All rights reserved.
Privacy
Your Privacy Choices
Cookies Preference
Terms of Use
Site Map
Pharmaceutical Licensing
PrivacyPrivacy
Your Privacy ChoicesYour Privacy Choices
Cookies PreferenceCookies Preference
Terms of UseTerms of Use
Site MapSite Map
Pharmaceutical LicensingPharmaceutical Licensing
  1. Home
  2. All Products
  3. Categories
  4. Rx Prescriptions
  5. Immune Globulins
  6. Human Rabies Immunoglobulin (HRIG)

KEDRAB™ Rabies Immune Globulin (Human) 150 IU/mL Injection for Rabies Postexposure Prophylaxis

USAMP#33903007SKU: 76125015002KEDRAB™
rxLicense

License Required

productImage

Product Spotlight

  • KEDRAB™ is a preservative-free Human Rabies Immunoglobulin (HRIG) designed for passive, transient postexposure prophylaxis (PEP) of rabies infection, effective when administered immediately after exposure to a rabid or potentially rabid animal.
  • For optimal efficacy, KEDRAB should be used in conjunction with a complete rabies vaccination series.
  • Each 2-mL single-dose vial delivers a total of 300 IU of HRIG, catering specifically to pediatric patients weighing up to 15 kg (33 lbs).
  • Depending on the patient's weight and the severity of exposure, treatment may necessitate multiple vials.